China related Press Releases
Asia Pacific Orthopedic Biomaterials Market to Grow to $1.3 Billion by 2016
Chinese Market to See Particularly Strong Growth in Hyaluronic Acid Viscosupplementation Treatments, According to Millennium Research Group TORONTO--(BUSINESS WIRE)-- According to Millennium Research Read more...
China Emerging as an Innovation Hub for Formulation and Delivery
China Emerging as an Innovation Hub for Formulation and Delivery The rise of Chinese start-ups and the frenzied forays of Western companies into the world's fastest-growing biopharmaceutical market Read more...
Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
CARLSBAD, Calif., Jan. 16, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that it has signed an agreement with DaAn Gene, a leading Chinese company in molecular Read more...
Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
Agreement Positions China as a Critical Player in the TB Vaccine Field ROCKVILLE, Md. and BEIJING, Jan. 10, 2012 /PRNewswire-USNewswire/ -- The global fight against the tuberculosis epidemic receives Read more...
For the Treatment of Type 2 Diabetes, the Vast Majority of Surveyed Physicians in China and South Korea Indicate That Ther
Interviewed South Korean Payers Expect Victoza and Bydureon To Be Reimbursed Under National Health Insurance, According to a New Report from Decision Resources BURLINGTON, Mass.--(BUSINESS WIRE)-- Read more...
China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
HARBIN, China, Dec. 16, 2011 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI), a leading fully integrated pharmaceutical company in the Read more...
Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
PRINCETON, NJ and NANJING, China, Dec. 13, 2011 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company in China, Read more...
ICON Acquires BeijingWits Medical Consulting Ltd
Acquisition Strengthens ICON’s Presence & Capabilities in China DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the Read more...
Merck Establishes New MSD R&D Asia Headquarters
Commits $1.5 Billion to R&D in China Over The Next 5 Years WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co., Inc., (NYSE:MRK), known as MSD outside the United States and Canada, today Read more...
Biotechnology Industry Organization Sponsors BIO China 2011, Oct 12 - 13, 2011, in Shanghai, CN
WASHINGTON--(BUSINESS WIRE)-- Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO-China-2011/PressKit/ Company:Biotechnology Industry OrganizationEvent:BIO China 2011Oct 12 Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
